Journaling Intervention for Temporomandibular Disorder (TMD) and Chronic Overlapping Pain
Launched by UNIVERSITY OF FLORIDA · May 8, 2025
Trial Information
Current as of July 04, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a 2-week gratitude journaling activity can help individuals with Temporomandibular Disorder (TMD) and chronic overlapping pain. The researchers want to find out if people can easily do the journaling, if they find it helpful, and whether it can reduce their pain and improve their daily life. Participants will be asked to write in their journal on three days each week, alongside attending two in-person visits where they will complete questionnaires and tests to measure their sensitivity to pressure and heat.
To be eligible for this study, participants should be between 18 and 80 years old, have pain in the jaw or temple area for at least three months, and rate their average pain as 4 or higher on a scale from 0 to 10. They should also have at least one additional chronic pain condition like fibromyalgia or migraines. It's important to note that certain people, such as those who have had TMD surgery or are currently pregnant, cannot participate. The study is not yet recruiting participants, but it offers a unique opportunity for those dealing with TMD and chronic pain to explore a potential new way to manage their symptoms.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • participants between the ages of 18 and 80
- • pain in the temporomandibular (TMD) region (jaw and/or temple area)
- • duration of pain is at least 3 months
- • average pain score ≥4 on a 0-10 numerical rating scale over the past week
- • have at least one additional chronic overlapping pain condition (COPC) including fibromyalgia, irritable bowel syndrome, migraine-type headache, tension-type headache, low back pain, interstitial cystitis/painful bladder syndrome or chronic prostatitis, myalgic encephalomyelitis/chronic fatigue syndrome, vulvodynia, and painful endometriosis.
- • able to read, understand, and write in English.
- Exclusion Criteria:
- • history of TMD surgery
- • neoplasm or injury/trauma to the TMD area
- • cancer-related pain
- • scheduled for any surgeries during the study time-frame
- • current participation in another clinical trial or psychological treatment for any pain-related condition that would interfere with study outcomes
- • pregnant or lactating
- • severe motor impairments (e.g., muscular dystrophy)
- • severe psychiatric conditions (e.g., uncontrolled mood disorders)
- • severe neurological or cognitive impairments (e.g., uncontrolled Parkinson's disease)
- • any other conditions that in the opinion of study investigators could make participation in the study unsafe
- • use of opioids within 48 hours prior to laboratory visit
About University Of Florida
The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gainesville, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported